Delivery Order SPE2DB22D3016-SPE2DB25FAZM5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Prevnar 20 vaccine in 0.5 milliliter syringes. This competitive, non-set-aside contract is valued at $16,984.67 and carries a completion date of September 3, 2025. The award will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this...
- The Defense Logistics Agency awarded a $10,990.43 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Prevnar 20 vaccine in 0.5 milliliter syringes. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability to meet...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,337.70 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 vaccine in 0.5ML syringes. This non-competitive delivery order was awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, and is priced on a firm fixed price basis. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine syringes (0.5mL) with a ceiling value of $37,805.76 under a firm fixed-price contract type. The award was made on September 19, 2025, with an ultimate completion date of September 22, 2025, and represents a non-competitive, competitively awarded delivery order. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Prevnar 20 vaccine syringes (0.5mL) with a contract ceiling value of $3,686.72. This is a firm fixed price delivery order with an ultimate completion date of August 13, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The award used no set-aside designation, indicating it was...
- The Defense Logistics Agency awarded a $46,889.08 delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Prevnar 20 vaccine in 0.5ML syringes. This firm fixed price contract, which is not set-aside, represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in syringe form (0.5 mL), valued at $1,633.77 with a firm fixed price structure. The contract represents a non-competitive delivery order issued on April 30, 2025, with an ultimate completion date of May 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was issued without set-aside designation, indicating competitive...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,535.12 for PREVNAR 20 Syringe 0.5ML on July 11, 2025, with completion scheduled for July 14, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single-line pharmaceutical procurement under the company's broader relationship...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Prevnar 20 vaccine in 0.5ML syringes. This $10,328.81 firm fixed-price delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, is scheduled for completion by August 18, 2025. The award was made through competitive procurement with no set-aside designation. AmerisourceBergen, a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in syringe form (0.5 mL), with a contract ceiling value of $15,832.38. This firm fixed-price delivery order was competitively awarded without set-aside provisions and carries an ultimate completion date of April 25, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania, serving as the prime contractor on this engagement. This...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FAZM5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Prevnar 20 vaccine syringes (0.5ml) under a firm fixed-price contract valued at $38,447.05, with completion scheduled for June 17, 2025. This non-competitive, competitively awarded delivery order represents a small procurement from AmerisourceBergen's existing pharmaceutical supply relationship with the federal government. The vaccine is to be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a prime pharmaceutical vendor supporting military healthcare systems globally, AmerisourceBergen leverages this comprehensive contract vehicle to supply vaccines, medications, and medical supplies across multiple therapeutic domains to the Defense Health Agency and other federal healthcare customers. The company's role as a critical pharmaceutical distributor for federal medical procurement demonstrates its established capability to fulfill government vaccine and medication supply requirements through competitive contracting.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.4k | 6/16/25 |